About Medi Schwall Pharma Private Limited
Data last updated:
Medi Schwall Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 19 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC329435. Its GSTIN is 27AAMCM8850H1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Syed Aman Asrar Quadri and Syed Asrar Viqaroddin Quadri.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.17 Gut No. 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2024, the company reported a revenue of ₹28.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹60,739 (net margin 2.1%) and EBITDA of ₹72,911 (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 202% over three years.
The company is associated with 1 brand: Azad Labs.
For more details, the company can be reached via its website medischwallpharma.azadlabs.com.
- EmailLocked
- TelephoneLocked
- Social MediaLocked
- Registered AddressPlot No.17 Gut No. 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, India – 431001
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medi Schwall Pharma Private Limited
The main business activity of Medi Schwall Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medi Schwall Pharma Private Limited FY 2025 filings available
Medi Schwall Pharma Private Limited reported revenue of ₹28.8 Lakh (up 204% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Medi Schwall Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 202% over three years, including 204% growth in the latest year. EBITDA rose 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medi Schwall Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹72,911 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60,739 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medi Schwall Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medi Schwall Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medi Schwall Pharma Private Limited
Medi Schwall Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inaya Diagnostics Private Limited | ₹28.97 Lakh (FY 2025) | •••• | •••• | 20.0% | •••• | Hisar, Haryana, India |
| Star Centre for Advanced Cardiology Private Limited | ₹28.91 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Medhekar Healthcare Private Limited | ₹28.9 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Solano Healthcare Private Limited | ₹28.87 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Ahmedabad, Gujarat, India |
| Nutrition Works Healthcare Services Private Limited | ₹28.85 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Medi Schwall Pharma Private Limited this company | ₹28.8 Lakh (FY 2024) | •••• | •••• | 204.0% | •••• | Aurangabad, Maharashtra, India |
| Labsakha Diagnostics Private Limited | ₹28.75 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | New Delhi, Delhi, India |
| Girija Fitness Private Limited | ₹28.74 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Patna, Bihar, India |
| Revive Healthcare Private Limited | ₹28.73 Lakh (FY 2018) | •••• | •••• | -79.0% | •••• | Baddi, Himachal Pradesh, India |
| Madagoni Pharmaceutical Services Private Limited | ₹28.72 Lakh (FY 2025) | •••• | •••• | -63.0% | •••• | Hyderabad, Telangana, India |
| Dr Geetha's CT Scans Private Limited | ₹28.72 Lakh (FY 2020) | •••• | •••• | 50.0% | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Medi Schwall Pharma by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medi Schwall Pharma Private Limited
Medi Schwall Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Aman Asrar Quadri | Director | 10 May 2023 | 3 Years 4 Months | Current |
| Syed Asrar Viqaroddin Quadri | Director | 30 Sep 2025 | 1 Years 0 Months | Current |
| Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui | Director | 19 Aug 2019 | 7 Years 1 Months | Current |
| Tahura Siddiqui Mujahed | Director | 30 Sep 2025 | 1 Years 0 Months | Current |
Ownership and Shareholding of Medi Schwall Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medi Schwall Pharma Private Limited
Medi Schwall Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Medi Schwall Pharma Private Limited
Medi Schwall Pharma operates one associated brand: Azad Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers web and mobile development, digital marketing, and training services. | azadlabs.com |
Employees and EPFO Compliance at Medi Schwall Pharma Private Limited
Employment history and EPFO contributions of people linked to Medi Schwall Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medi Schwall Pharma Private Limited
Medi Schwall Pharma Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Syed Asrar Viqaroddin Quadri was appointed as Director on 30 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Medi Schwall Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medi Schwall Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medi Schwall Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medi Schwall Pharma Private Limited
Medi Schwall Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCM8850H1ZY | Maharashtra | Active | 24 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medi Schwall Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medi Schwall Pharma Private Limited
Medi Schwall Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U24304MH2019PTC329435.
Medi Schwall Pharma reported revenue of ₹28.8 Lakh for FY 2024 (up 204% YoY).
Medi Schwall Pharma has 4 current directors:
- Syed Aman Asrar Quadri - Director
- Syed Asrar Viqaroddin Quadri - Director
- Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui - Director
- Tahura Siddiqui Mujahed - Director
Medi Schwall Pharma reported a net profit of ₹60,739 (net margin 2.1%) and EBITDA of ₹72,911 (EBITDA margin 2.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medi Schwall Pharma is 202% over three years. In the latest year (FY 2024) revenue rose 204%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medi Schwall Pharma is 27AAMCM8850H1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medi Schwall Pharma is U24304MH2019PTC329435. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medi Schwall Pharma was incorporated on 19 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medi Schwall Pharma by revenue are Inaya Diagnostics Private Limited, Star Centre for Advanced Cardiology Private Limited, Medhekar Healthcare Private Limited, Solano Healthcare Private Limited, Nutrition Works Healthcare Services Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Syed Asrar Viqaroddin Quadri was appointed as Director on 30 Sep 2025. Tahura Siddiqui Mujahed was appointed as Director on 30 Sep 2025. Syed Aman Asrar Quadri was appointed as Director on 10 May 2023. Medi Schwall Pharma has 5 board changes on record in total.
Yes, Medi Schwall Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).